<DOC>
	<DOCNO>NCT01769898</DOCNO>
	<brief_summary>The purpose study examine efficacy safety 24 week treatment theophylline plus low-dose formoterol-budesonide subject bronchiectasis .</brief_summary>
	<brief_title>The Role Theophylline Plus Low-dose Formoterol-budesonide Treatment Bronchiectasis</brief_title>
	<detailed_description>Non-cystic fibrosis bronchiectasis orphan disease cause pathogenic vicious circle include infection , inflammation airway repair . Today 's principle treatment break cycle inflammation infection . Nowadays , clinical trial anti-infective treatment antibiotic try break cycle reduce bacterial load , may cause bacterial resistance . There still anti-inflammation trial use inhaled corticosteroid ( ICS ) . Tsang Martínez-García show inhaled corticosteroid reduce IL-1 , IL-8 level sputum inflammation cell , improve sputum volume well quality life , though corticosteroid must high dose medium dose combine long-acting ß2 adrenergic agonist . As described asthma chronic obstructive pulmonary disease ( COPD ) , theophylline improve activity histone deacetylase ( HDAC ) enhance anti-inflammatory effect steroid . We hypothesis theophylline may effect subject bronchiectasis . Theophylline plus inhaled low-dose formoterol-budesonide may improve quality life reduce airway inflammation .</detailed_description>
	<mesh_term>Bronchiectasis</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Patients 1870 year old noncystic fibrosis ( CF ) bronchiectasis , free acute exacerbation least 3 months.Stable phase disease . Patients cigarette smoke history 10 packsyear . Patients COPD . Patients traction bronchiectasis due advance fibrosis . Patients know intolerance theophylline . Patients asthma . Patients disease disturb outcomes trial . Patients without consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Bronchiectasis</keyword>
	<keyword>Theophylline</keyword>
	<keyword>Therapeutic Uses</keyword>
	<keyword>HDAC</keyword>
	<keyword>HAT</keyword>
	<keyword>Random placebo study</keyword>
	<keyword>ICS ( inhale corticosteroid )</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>Inhaled corticosteroid</keyword>
</DOC>